Gene: ARSA
Official Full Name: arylsulfatase Aprovided by HGNC
Gene Summary: The protein encoded by this gene hydrolyzes cerebroside sulfate to cerebroside and sulfate. Defects in this gene lead to metachromatic leucodystrophy (MLD), a progressive demyelination disease which results in a variety of neurological symptoms and ultimately death. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Dec 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO38915 | ARSA Knockout cell line (HeLa) | Human | ARSA | 1:3~1:6 | Negative | Online Inquiry |
KO38916 | ARSA Knockout cell line (HCT 116) | Human | ARSA | 1:2~1:4 | Negative | Online Inquiry |
KO38917 | ARSA Knockout cell line (HEK293) | Human | ARSA | 1:3~1:6 | Negative | Online Inquiry |
KO38918 | ARSA Knockout cell line (A549) | Human | ARSA | 1:3~1:4 | Negative | Online Inquiry |
ARSA Gene Knockout Cell Lines are advanced genetic models engineered for studying the implications of Arylsulfatase A (ARSA) gene deficiency in various cellular contexts. These cell lines are derived from parent cells in which the ARSA gene is precisely disrupted, enabling researchers to investigate the consequences of its absence, notably in relation to disorders such as Metachromatic Leukodystrophy (MLD). The mechanisms at play include impaired sulfatase activity, which leads to the accumulation of sulfatides and subsequent neurodegeneration and cellular dysregulation.
In both research and clinical settings, ARSA Gene Knockout Cell Lines serve as pivotal tools for elucidating biochemical pathways and testing therapeutic interventions. They provide a robust platform for drug discovery and development, allowing scientists to screen compounds that can potentially restore ARSA function or mitigate the effects of its deficiency. Additionally, these cell lines are invaluable for studying gene therapy methods, where they can serve as a model for assessing corrective strategies aimed at restoring normal cellular physiology.
One of the specific advantages of ARSA Gene Knockout Cell Lines is their precision and reproducibility, which surpasses the limitations of in vivo models or less specific knockdown strategies. Unlike existing alternatives, these knockout lines enable targeted studies of ARSA-related cellular mechanisms without the confounding factors present in mixed genetic backgrounds. This specificity enhances the reliability of the results, making these cell lines indispensable for rigorous scientific exploration.
The value of ARSA Gene Knockout Cell Lines to researchers and clinicians lies in their ability to accelerate the understanding of monogenic disorders and facilitate the development of innovative therapies. By utilizing these models, professionals can contribute to advancing precision medicine and optimizing patient outcomes with targeted treatments for ARSA-related conditions.
Our company's expertise in genetic engineering and cell line development positions us as a leading provider of specialized biological tools, ensuring that our products meet the highest standards of quality and scientific excellence. With ARSA Gene Knockout Cell Lines, we empower researchers to unlock new pathways in disease research and therapeutic development.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.